CDCharles Z. Ding
Charles Z. Ding
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Charles Z. Ding has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Gary K. Smith
GlaxoSmithKline, Five Moore Drive, Research Triangle Park, NC 27709, USA
2 shared publicationsJacob J. Plattner
Anacor Pharmaceuticals, Inc., 1020 E. Meadow Circle, Palo Alto, CA 94303, USA
2 shared publicationsJon Wright
BioDuro LLC, Building E, No. 29, Life Science Park Road, Beijing 102206, PR China
2 shared publicationsLiang Liu
Anacor Pharmaceuticals, Inc., 1020 E. Meadow Circle, Palo Alto, CA 94303, USA
2 shared publicationsLois L. Wright
GlaxoSmithKline, Five Moore Drive, Research Triangle Park, NC 27709, USA
2 shared publicationsRenae M. Crosby
GlaxoSmithKline, Five Moore Drive, Research Triangle Park, NC 27709, USA
2 shared publications
Latest Publications
- 15 December 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (24) , 7493-7497
Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 protease
- 15 December 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (24) , 7493-7497
Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 protease
- 1 December 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (24) , 7317-7322
Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 protease
- 1 December 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (24) , 7317-7322
Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 protease